OTC Healthcare in Canada published by Euromonitor International in April, 2009. This report consists of Tables 102 and the price starts from US $ 2400.
Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products;
Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies;
Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated
skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans;
Vitamins and dietary supplements; Wound treatments
Executive summary
Quiet year and slow growth of mature market
The Canadian OTC healthcare market continued to grow in 2008, albeit at a very
slow pace in contrast to the previous year and the review period as a whole
when a number of new medications, including those switched to OTC status, hit
the shelves. However, 2008 was a quiet year. Subsequently, mature market
conditions, lack of substantial product innovation and OTC switches as well as
inability of manufacturers and retailers to raise prices at retail contributed
to slow value growth in the Canadian market for OTC healthcare.
Ageing population remains the principal driver of sales
Canadian society is ageing, and the proportion of people age 65 years and over
continues to rise while the birth rate remains low. Although living healthier
lives, older Canadians require medical attention more often than younger
Canadians. Moreover, in addition to prescription drugs, ageing Canadian
consumers are frequent users of OTC treatments. The impact of these trends is
particularly felt in continuous demand and good sales of adult analgesics as
well as digestive remedies, a number of medicated skin care products, wound
treatments and some others. Examples of the products that are specifically
recommended to and used by older consumers include low-dose ASA as a
preventive against heart attack and stroke, and low-dose ASA remains the
driving force behind sales of aspirin in Canada.
Private label gained ground
As of 2006, the Canadian OTC healthcare market has become more consolidated,
with Johnson & Johnson (through its subsidiary McNeil Consumer Healthcare) and
Wyeth in the lead and battling for consumer attention in a number of OTC
sectors, most notably analgesics. However, the development of cheaper private
label products, especially given the current economic downturn, has attracted
the attention of a rising number of Canadians. As a result, in 2008 the
performance of private label at retail improved significantly, in some cases
outpacing share gains registered by branded products, allergy remedies being a
case in point.
Chained parapharmacies/drugstores lead OTC distribution
Chemists/pharmacies and parapharmacies/drugstores account for the largest
share of OTC sales in Canada. Leading chained parapharmacies/drugstores,
however, are particularly successful in retaining and expanding their customer
base. Not only do they continue to open new outlets and dominate urban
landscapes, thus being within easy reach of their customers, but Canadian
chained parapharmacies/drugstores feature a great selection of non-medicinal
merchandise, including fast growing mass and prestige beauty care, and
extended customer services, thereby making ' one-stop shopping' easier,
especially for the growing number of elderly customers.
Slow growth is expected in the coming years
The growing proportion of ageing Canadians will help to support sales of OTC
healthcare in Canada over 2008-2013. However, market maturity, growing
presence of cheaper private label in many OTC sectors -- particularly
attractive to many consumers in times of economic difficulty -- and inability
of pharmaceutical companies to raise prices significantly due to the
government control over retail prices of medications will inhibit value growth
in the coming years. Furthermore, Canadians are leading increasingly healthier
lifestyles, thereby keeping ailments at bay and minimising the need for
medical treatment, which is also likely to slow demand for OTC drugs over the
forecast period.
Table of Contents
- OTC HEALTHCARE IN CANADA : MARKET INSIGHT
- EXECUTIVE SUMMARY
- Quiet year and slow growth of mature market
- Ageing population remains the principal driver of sales
- Private label gained ground
- Chained parapharmacies/drugstores lead OTC distribution
- Slow growth is expected in the coming years
- KEY TRENDS AND DEVELOPMENTS
- Ageing population and tendency to self-medicate remain primary growth
drivers
- Private label is gaining ground as economy weakens
- Most natural remedies are struggling
- Foreign-based manufacturers lead sales
- Large drugstore chains still prevail in distribution of OTC healthcare
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2008-2013
- APPENDIX
- OTC Registration and Classification
- Self-medication and Preventive Medicine
- Generics
- Switches
- Summary 1 OTC Healthcare Switches 2005-2008
- DEFINITIONS
- Summary 2 Research Sources
- LOCAL COMPANY PROFILES - CANADA
- APOTEX INC - OTC HEALTHCARE - CANADA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 3 Apotex Inc: Key Facts
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- CE JAMIESON & CO LTD - OTC HEALTHCARE - CANADA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 4 CE Jamieson & Co Ltd: Key Facts
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 5 CE Jamieson & Co Ltd: Competitive Position 2008
- CV TECHNOLOGIES INC - OTC HEALTHCARE - CANADA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 6 CV Technologies Inc: Key Facts
- Summary 7 CV Technologies Inc: Operational Indicators
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 8 CV Technologies Inc: Competitive Position 2008
- PHARMASCIENCE INC - OTC HEALTHCARE - CANADA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 9 Pharmascience Inc: Key Facts
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 10 Pharmascience Inc: Competitive Position 2008
- SWISS HERBAL REMEDIES LTD - OTC HEALTHCARE - CANADA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 11 Swiss Herbal Remedies Ltd: Key Facts
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 12 Swiss Herbal Remedies Ltd: Competitive Position 2008
- ANALGESICS IN CANADA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 12 Sales of Analgesics by Subsector: Value 2003-2008
- Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
- Table 14 Herbal vs Standard Topical Analgesics 2003-2008
- Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
- Table 16 Analgesics Company Shares by Value 2004-2008
- Table 17 Analgesics Brand Shares by Value 2005-2008
- Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
- Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth
2008-2013
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CANADA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: Value 2003-2008
- Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2003-2008
- Table 22 Sales of Decongestants by Type: Value 2003-2008
- Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: Value 2003-2008
- Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: % Value Growth 2003-2008
- Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies
2003-2008
- Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by
Value 2004-2008
- Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by
Value 2005-2008
- Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2008-2013
- Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: % Value Growth 2008-2013
- DIGESTIVE REMEDIES IN CANADA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 31 Sales of Digestive Remedies by Subsector: Value 2003-2008
- Table 32 Sales of Digestive Remedies by Subsector: % Value Growth
2003-2008
- Table 33 Herbal vs Standard Digestive Remedies 2003-2008
- Table 34 Digestive Remedies Company Shares by Value 2004-2008
- Table 35 Digestive Remedies Brand Shares by Value 2005-2008
- Table 36 Forecast Sales of Digestive Remedies by Subsector: Value
2008-2013
- Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value
Growth 2008-2013
- MEDICATED SKIN CARE IN CANADA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 38 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth
2003-2008
- Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 41 Medicated Skin Care Company Shares by Value 2004-2008
- Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 43 Acne Treatments Brand Shares by Value 2005-2008
- Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
- Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value
2008-2013
- Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value
Growth 2008-2013
- VITAMINS AND DIETARY SUPPLEMENTS IN CANADA
- HEADLINES
- TRENDS -- VITAMINS
- TRENDS -- DIETARY SUPPLEMENTS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value
2003-2008
- Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value
Growth 2003-2008
- Table 49 Dietary Supplements: Share of Sales by Positioning 2006-2008
- Table 50 Folic Acid v Other B Vitamins 2004-2008
- Table 51 Dietary Supplements by Positioning 2006-2008
- Table 52 Vitamins and Dietary Supplements Company Shares by Value
2004-2008
- Table 53 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
- Table 54 Vitamins Brand Shares by Value 2005-2008
- Table 55 Dietary Supplements Brand Shares by Value 2005-2008
- Table 56 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: Value 2008-2013
- Table 57 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: % Value Growth 2008-2013
- NRT SMOKING CESSATION AIDS IN CANADA
- HEADLINES
- TRENDS
- SWITCHES
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR INDICATORS
- Table 58 Number of Smokers by Gender 2003-2008
- SECTOR DATA
- Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth
2003-2008
- Table 61 NRT Gum Flavours: % Value Breakdown 2006-2008
- Table 62 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 63 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value
2008-2013
- Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value
Growth 2008-2013
- EYE CARE IN CANADA
- TRENDS
- SECTOR DATA
- Table 66 Sales of Eye Care by Subsector: Value 2003-2008
- Table 67 Sales of Eye Care by Subsector: % Value Growth 2003-2008
- Table 68 Standard Eye Care by Type: % Value Breakdown 2007-2008
- Table 69 Eye Care Company Shares by Value 2004-2008
- Table 70 Eye Care Brand Shares by Value 2005-2008
- Table 71 Forecast Sales of Eye Care by Subsector: Value 2008-2013
- Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth
2008-2013
- EAR CARE IN CANADA
- TRENDS
- SECTOR DATA
- Table 73 Sales of Ear Care: Value 2003-2008
- Table 74 Sales of Ear Care: % Value Growth 2003-2008
- Table 75 Ear Care Company Shares by Value 2004-2008
- Table 76 Ear Care Brand Shares by Value 2005-2008
- Table 77 Forecast Sales of Ear Care: Value 2008-2013
- Table 78 Forecast Sales of Ear Care: % Value Growth 2008-2013
- ADULT MOUTH CARE IN CANADA
- HEADLINES
- SECTOR DATA
- Table 79 Sales of Adult Mouth Care: Value 2003-2008
- Table 80 Sales of Adult Mouth Care: % Value Growth 2003-2008
- Table 81 Adult Mouth Care Company Shares by Value 2004-2008
- Table 82 Adult Mouth Care Brand Shares by Value 2005-2008
- Table 83 Forecast Sales of Adult Mouth Care: Value 2008-2013
- Table 84 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
- CALMING AND SLEEPING PRODUCTS IN CANADA
- TRENDS
- SECTOR DATA
- Table 85 Sales of Calming and Sleeping Products: Value 2003-2008
- Table 86 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
- Table 87 Calming and Sleeping Products Company Shares by Value 2004-2008
- Table 88 Calming and Sleeping Products Brand Shares by Value 2005-2008
- Table 89 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
- Table 90 Forecast Sales of Calming and Sleeping Products: % Value Growth
2008-2013
- WOUND TREATMENTS IN CANADA
- TRENDS
- SECTOR DATA
- Table 91 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 92 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
- Table 93 Wound Treatments Company Shares by Value 2004-2008
- Table 94 Wound Treatments Brand Shares by Value 2005-2008
- Table 95 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 96 Forecast Sales of Wound Treatments by Subsector: % Value Growth
2008-2013
- EMERGENCY CONTRACEPTION IN CANADA
- TRENDS
- SECTOR DATA
- Table 97 Sales of Emergency Contraception: Value 2003-2008
- Table 98 Sales of Emergency Contraception: % Value Growth 2003-2008
- Table 99 Emergency Contraception Company Shares by Value 2004-2008
- Table 100 Emergency Contraception Brand Shares by Value 2005-2008
- Table 101 Forecast Sales of Emergency Contraception: Value 2008-2013
- Table 102 Forecast Sales of Emergency Contraception: % Value Growth
2008-2013
